20-Jul-2022 | D | Pursuant to Regulation 30 of SEBI (LODR), it is hereby informed that the Board has declared Interim Dividend of 2.5% i.e. Rs. 0.25 per equity share of face value of Rs.10/- each for the year 2022-23.
| 29-Jul-2022 | |
30-Aug-2017 | D | Zenlabs Ethica Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 30, 2017, inter alia, has approved the following :
- Board recommends dividend at the rate of Rs. 0.25 per Equity Share of the Company for the financial year ended March 31, 2017 subject to approval of shareholder at the ensuing 24th Annual General Meeting of the Company. | 20-Sep-2017 | |
03-Oct-2018 | B | 1:20 Bonus Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, Zenlabs Ethica Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Zenlabs Ethica Limited
(530697)
RECORD DATE
13/10/2018
PURPOSE
Issue of 01 (One) Bonus equity share of Rs.10/- each for every 20 (Twenty) existing equity shares of Rs.10/- each held.
Ex-Bonus basis from Date & Sett. No.
11/10/2018 DR-135/2018-2019
Trading Members of the Exchange are requested to take of it.
(As Per BSE Notice Dated on 05.10.2018) | 13-Oct-2018 | 1:20 |
26-Mar-2024 | BC | Hitesh Popatlal Oswal | 22-Mar-2024 | |
26-Mar-2024 | BC | Preet Remedies Ltd | 22-Mar-2024 | |
22-Jan-2024 | BC | Zenlabs Ethica Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve Un-Audited Financial Results of the Company | 29-Jan-2024 | |
26-Oct-2023 | BC | Zenlabs Ethica Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Meeting of Board of Directors of Zenlabs Eth | 06-Nov-2023 | |
19-Oct-2023 | BC | Pursuant to the provision of Regulation 30 of SEBI (LODR) Regulations read with Schedule III, we wish to inform you that Mr. Ashok Gupta (DIN: 07330108) has tendered his resignation from the position | 18-Oct-2023 | |
Announcement Date20-Jul-2022
Ex Dividend Date29-Jul-2022
Dividend(%)2
Announcement Date30-Aug-2017
Ex Dividend Date20-Sep-2017
Dividend(%)2
Record Date13-Oct-2018
Ex-Bonus Date11-Oct-2018
Ratio1:20
No Split has been declared by Zenlabs_Ethica
RightsNo Rights has been declared by Zenlabs_Ethica
Book Closure
22-Mar-2024 | - | Hitesh Popatlal Oswal |
22-Mar-2024 | - | Preet Remedies Ltd |
29-Jan-2024 | - | Zenlabs Ethica Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve Un-Audited Financial Results of the Company |
06-Nov-2023 | - | Zenlabs Ethica Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Meeting of Board of Directors of Zenlabs Eth |
18-Oct-2023 | - | Pursuant to the provision of Regulation 30 of SEBI (LODR) Regulations read with Schedule III, we wish to inform you that Mr. Ashok Gupta (DIN: 07330108) has tendered his resignation from the position |